Cognitive and functional impairment in hypertensive brain microangiopathy

Journal of the Neurological Sciences

Volumn 257, Issue 1-2, 2007, Pages 166-173

  Inzitari, Marco ^a   Pozzi, Claudia ^a   Rinaldi, Lucio A ^a,b   Masotti, Giulio ^a,b   Marchionni, Niccolò ^a   Di Bari, Mauro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Centro di Riabilitazione   (Italy)

Author keywords

Age related white matter changes; Cognitive function; Disability; Gait; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL;

ADULT; AGE RELATED WHITE MATTER CHANGE; AGED; ARTICLE; BRAIN MICROCIRCULATION; COGNITIVE DEFECT; ELDERLY CARE; GAIT; GERIATRIC CARE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MICROANGIOPATHY; MOTOR PERFORMANCE; NEUROIMAGING; PHYSICAL DISABILITY; PRIORITY JOURNAL; WHITE MATTER;

BRAIN; CEREBRAL ARTERIES; COGNITION DISORDERS; GAIT DISORDERS, NEUROLOGIC; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL HYPERTENSION; MICROCIRCULATION; MOVEMENT DISORDERS; NERVE FIBERS, MYELINATED;

EID: 34249870393     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.026     Document Type: Article

References (71)

1. Roman G.C., Erkinjuntti T., Wallin A., Pantoni L., and Chui H.C. Subcortical ischaemic vascular dementia. Lancet Neurol 1 7 (2002) 426-436
2. de Leeuw F.E., de Groot J.C., and Breteler M.M. White matter changes: frequency and risk factors. In: Pantoni L., Inzitari D., and Wallin A. (Eds). The matter of white matter (2000), Academic Pharmaceutical Productions, Utrecht, The Netherlands 19-33
3. Inzitari D., Diaz F., Fox A., Hachinski V.C., Steingart A., Lau C., et al. Vascular risk factors and leuko-araiosis. Arch Neurol 44 1 (1987) 42-47
4. Breteler M.M., van Swieten J.C., Bots M.L., Grobbee D.E., Claus J.J., van den Hout J.H., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44 7 (1994) 1246-1252
5. Liao D., Cooper L., Cai J., Toole J.F., Bryan N.R., Hutchinson R.G., et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 27 12 (1996) 2262-2270
6. Longstreth Jr. W.T., Manolio T.A., Arnold A., Burke G.L., Bryan N., Jungreis C.A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27 8 (1996) 1274-1282
7. de Leeuw F.E., de Groot J.C., Oudkerk M., Witteman J.C., Hofman A., van Gijn J., et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125 Pt 4 (2002) 765-772
8. van Dijk E.J., Breteler M.M., Schmidt R., Berger K., Nilsson L.G., Oudkerk M., et al. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 44 5 (2004) 625-630
9. Longstreth Jr. W.T., Arnold A.M., Beauchamp Jr. N.J., Manolio T.A., Lefkowitz D., Jungreis C., et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 36 1 (2005) 56-61
10. Marti-Fabregas J., Valencia C., Pujol J., Garcia-Sanchez C., Roca-Cusachs A., Lopez-Contreras J., et al. Blood pressure variability and leukoaraiosis amount in cerebral small-vessel disease. Acta Neurol Scand 104 6 (2001) 358-363
11. Puisieux F., Monaca P., Deplanque D., Delmaire C., di Pompeo C., Monaca C., et al. Relationship between leuko-araiosis and blood pressure variability in the elderly. Eur Neurol 46 3 (2001) 115-120
12. Sander D., Winbeck K., Klingelhofer J., and Conrad B. Extent of cerebral white matter lesions is related to changes of circadian blood pressure rhythmicity. Arch Neurol 57 9 (2000) 1302-1307
13. Kukla C., Sander D., Schwarze J., Wittich I., and Klingelhofer J. Changes of circadian blood pressure patterns are associated with the occurrence of lucunar infarction. Arch Neurol 55 5 (1998) 683-688
14. Yamamoto Y., Akiguchi I., Oiwa K., Hayashi M., Kasai T., and Ozasa K. Twenty-four-hour blood pressure and MRI as predictive factors for different outcomes in patients with lacunar infarct. Stroke 33 1 (2002) 297-305
15. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 13 Suppl 2 (2002) 7-10
16. Manolio T.A., Olson J., and Longstreth W.T. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep 5 3 (2003) 255-261
17. Strittmatter M., Meyer S., Fischer C., Georg T., and Schmitz B. Location-dependent patterns in cardio-autonomic dysfunction in ischaemic stroke. Eur Neurol 50 1 (2003) 30-38
18. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347 9009 (1996) 1141-1145
19. Qiu C., Winblad B., and Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4 8 (2005) 487-499
20. Sierra C., De La S.A., Salamero M., Sobrino J., Gomez-Angelats E., and Coca A. Silent cerebral white matter lesions and cognitive function in middle-aged essential hypertensive patients. Am J Hypertens 17 6 (2004) 529-534
21. Elias P.K., Elias M.F., Robbins M.A., and Budge M.M. Blood pressure-related cognitive decline: does age make a difference?. Hypertension 44 5 (2004) 631-636
22. Kuo H.K., Sorond F., Iloputaife I., Gagnon M., Milberg W., and Lipsitz L.A. Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci 59 11 (2004) 1191-1194
23. Oosterman J.M., Sergeant J.A., Weinstein H.C., and Scherder E.J. Timed executive functions and white matter in aging with and without cardiovascular risk factors. Rev Neurosci 15 6 (2004) 439-462
24. Dufouil C., Alperovitch A., and Tzourio C. Influence of education on the relationship between white matter lesions and cognition. Neurology 60 5 (2003) 831-836
25. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
26. van der Flier W.M., van Straaten E.C., Barkhof F., Verdelho A., Madureira S., Pantoni L., et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 36 10 (2005) 2116-2120
27. van Swieten J.C., Geyskes G.G., Derix M.M., Peeck B.M., Ramos L.M., van Latum J.C., et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 30 6 (1991) 825-830
28. Junque C., Pujol J., Vendrell P., Bruna O., Jodar M., Ribas J.C., et al. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 47 2 (1990) 151-156
29. de Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 47 2 (2000) 145-151
30. Roman G.C., Sachdev P., Royall D.R., Bullock R.A., Orgogozo J.M., Lopez-Pousa S., et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 226 1-2 (2004) 81-87
31. Desmond D.W. Cognition and white matter lesions. Cerebrovasc Dis 13 Suppl 2 (2002) 53-57
32. Mosley Jr. T.H., Knopman D.S., Catellier D.J., Bryan N., Hutchinson R.G., Grothues C.A., et al. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 64 12 (2005) 2056-2062
33. Ylikoski R., Ylikoski A., Erkinjuntti T., Sulkava R., Raininko R., and Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 50 8 (1993) 818-824
34. Baezner H., and Hennerici M. From trepidant abasia to motor network failure-gait disorders as a consequence of subcortical vascular encephalopathy (SVE): review of historical and contemporary concepts. J Neurol Sci 229-230 (2005) 81-88
35. Odenheimer G., Funkenstein H.H., Beckett L., Chown M., Pilgrim D., Evans D., et al. Comparison of neurologic changes in 'successfully aging' persons vs the total aging population. Arch Neurol 51 6 (1994) 573-580
36. Verghese J., Le Valley A., Hall C., Katz M.J., Ambrose A.F., and Lipton R.B. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc. 54 2 (2006) 255-261
37. Bazner H., Oster M., Daffertshofer M., and Hennerici M. Assessment of gait in subcortical vascular encephalopathy by computerized analysis: a cross-sectional and longitudinal study. J Neurol 247 11 (2000) 841-849
38. Ebersbach G., Sojer M., Valldeoriola F., Wissel J., Muller J., Tolosa E., et al. Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain 122 Pt 7 (1999) 1349-1355
39. Rosano C., Brach J., Longstreth Jr. W.T., and Newman A.B. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology 26 1 (2005) 52-60
40. Baloh R.W., Yue Q., Socotch T.M., and Jacobson K.M. White matter lesions and disequilibrium in older people. I. Case-control comparison. Arch Neurol 52 10 (1995) 970-974
41. Masdeu J.C., Wolfson L., Lantos G., Tobin J.N., Grober E., Whipple R., et al. Brain white-matter changes in the elderly prone to falling. Arch Neurol 46 12 (1989) 1292-1296
42. Verghese J., Lipton R.B., Hall C.B., Kuslansky G., Katz M.J., and Buschke H. Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med 347 22 (2002) 1761-1768
43. Guralnik J.M., Simonsick E.M., Ferrucci L., Glynn R.J., Berkman L.F., Blazer D.G., et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49 2 (1994) M85-M94
44. Guralnik J.M., Ferrucci L., Simonsick E., Salive M.E., and Wallace R.B. Lower-extremity function in persons over the age of 70 years as predictor of subsequent disability. N Engl J Med 332 (1995) 556-561
45. Briley D.P., Wasay M., Sergent S., and Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 45 12 (1997) 1434-1438
46. Camicioli R., Moore M.M., Sexton G., Howieson D.B., and Kaye J.A. Age-related brain changes associated with motor function in healthy older people. J Am Geriatr Soc 47 3 (1999) 330-334
47. Guttmann C.R., Benson R., Warfield S.K., Wei X., Anderson M.C., Hall C.B., et al. White matter abnormalities in mobility-impaired older persons. Neurology 54 6 (2000) 1277-1283
48. Rosano C., Kuller L.H., Chung H., Arnold A.M., Longstreth Jr. W.T., and Newman A.B. Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. J Am Geriatr Soc 53 4 (2005) 649-654
49. Whitman G.T., Tang Y., Lin A., and Baloh R.W. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 57 6 (2001) 990-994
50. Wolfson L., Wei X., Hall C.B., Panzer V., Wakefield D., Benson R.R., et al. Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility. J Neurol Sci 232 1-2 (2005) 23-27
51. Inzitari D., Di Carlo A., Mascalchi M., Pracucci G., and Amaducci L. The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol 52 7 (1995) 687-691
52. Briley D.P., Haroon S., Sergent S.M., and Thomas S. Does leukoaraiosis predict morbidity and mortality?. Neurology 54 1 (2000) 90-94
53. Sachdev P.S., Wen W., Christensen H., and Jorm A.F. White matter hyperintensities are related to physical disability and poor motor function. J Neurol Neurosurg Psychiatry 76 3 (2005) 362-367
54. Pugh K.G., and Lipsitz L.A. The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 23 3 (2002) 421-431
55. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch Neurol 50 8 (1993) 873-880
56. Cook I.A., Leuchter A.F., Morgan M.L., Conlee E.W., David S., Lufkin R., et al. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Arch Neurol 59 10 (2002) 1612-1620
57. Sultzer D.L., Mahler M.E., Cummings J.L., Van Gorp W.G., Hinkin C.H., and Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Arch Neurol 52 8 (1995) 773-780
58. Rosano C., Aizenstein H., Cochran J., Saxton J., De Kosky S., Newman A.B., et al. Functional neuroimaging indicators of successful executive control in the oldest old. NeuroImage (2005)
59. Della Sala S., Francescani A., and Spinnler H. Gait apraxia after bilateral supplementary motor area lesion. J Neurol Neurosurg Psychiatry 72 1 (2002) 77-85
60. Benson R.R., Guttmann C.R., Wei X., Warfield S.K., Hall C., Schmidt J.A., et al. Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology 58 1 (2002) 48-55
61. Liston R., Mickelborough J., Bene J., and Tallis R. A new classification of higher level gait disorders in patients with cerebral multi-infarct states. Age Ageing 32 3 (2003) 252-258
62. Ble A., Volpato S., Zuliani G., Guralnik J.M., Bandinelli S., Lauretani F., et al. Executive function correlates with walking speed in older persons: the InCHIANTI study. J Am Geriatr Soc 53 3 (2005) 410-415
63. Forette F., Seux M.L., Staessen J.A., Thijs L., Birkenhager W.H., Babarskiene M.R., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 9137 (1998) 1347-1351
64. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., MacMahon S., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163 9 (2003) 1069-1075
65. Guo Z., Fratiglioni L., Zhu L., Fastbom J., Winblad B., and Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 56 8 (1999) 991-996
66. Di Bari M., Pahor M., Franse L.V., Shorr R.I., Wan J.Y., Ferrucci L., et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 153 1 (2001) 72-78
67. Dufouil C., Chalmers J., Coskun O., Besancon V., Bousser M.G., Guillon P., et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 112 11 (2005) 1644-1650
68. Schmidt R., Scheltens P., Erkinjuntti T., Pantoni L., Markus H.S., Wallin A., et al. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 63 1 (2004) 139-144
69. Baloh R.W., Ying S.H., and Jacobson K.M. A longitudinal study of gait and balance dysfunction in normal older people. Arch Neurol 60 6 (2003) 835-839
70. Starr J.M., Leaper S.A., Murray A.D., Lemmon H.A., Staff R.T., Deary I.J., et al. Brain white matter lesions detected by magnetic resonance [correction of resonance] imaging are associated with balance and gait speed. J Neurol Neurosurg Psychiatry 74 1 (2003) 94-98
71. Onen F., Feugeas M.C., Baron G., De Marco G., Godon-Hardy S., Peretti I.I., et al. Leukoaraiosis and mobility decline: a high resolution magnetic resonance imaging study in older people with mild cognitive impairment. Neurosci Lett 355 3 (2004) 185-188